President and CEO of DiaKine Therapeutics

‘We believe that the combination therapy of his Lisofylline and INGAP peptide has the potential to be a blockbuster drug,’said Keith D. President and CEO of DiaKine Therapeutics. ‘we believe that if successful, this new therapy could dramatically transform approach to the treatment of diabetes . ‘Kevin Roch Kinexum Metabolics CEO, added: ‘It is clear that we to a cure to a cure for type 1 diabetes if we do not use a combination of therapies. This cooperation is to do part of the plan protein, sooner than later. ‘.

About DiaKineDiaKine Therapeutics, is a development-stage company commercializing novel immune modulators initially targeting the treatment of autoimmune and inflammatory diseases such as diabetes and complications. These new drugs regulate cytokines, part of the body’s mistakenly mistakenly attacking tissue and inflammation. The company developed its first product, IsletLife LSF Media 1, the viability and harvested insulin-producing islet cells improve skills before the transplant. IsletLife LSF media 1thus potentially improve the success rate of the procedure. Other agents in development of DiaKine include: stop adjunctive therapy to cell transplants island, the progression of the type diabetes diabetes in newly diagnosed adults, treatment and prevention of latent autoimmune diabetes of adults , treatment and prevention of insulin type 2 diabetics, Treatment and prevention of diabetes complications.

NewYork-Presbyterian Hospital / Weill Cornell Medical Centerlocation NewYork-Presbyterian Hospital / Weill Cornell Medical Center New York City, is one of the leading academic medical centers in the world that. The teaching hospital for NewYork-Presbyterian and Weill Cornell Medical College, Medical School at Cornell University NewYork-Presbyterian/Weill Cornell provides state-of-the-art inpatient, outpatient and preventive care to all areas of medicine, and It is obligation Your Excellency of patient care, education, research and civilian. Weill Cornell medical – scholars responsible for many medical progress – from development of the pap smear screening for cervical cancer in the synthesis of penicillin, of the first successful embryos – biopsies pregnancy and birth in the U.S., the first clinical trial for the gene therapy of Parkinson’s disease, the first sign out of bone marrow , the important role in tumor growth, United recently, the world’s first successful use to the as deep brain stimulation treated minimally conscious cranial – injured people. NewYork-Presbyterian , which in sixth place the U.S. News and World Report list of the top hospitals, includes NewYork-Presbyterian Hospital / Columbia University Medical Center, Morgan Stanley Children’s Hospital, NewYork-Presbyterian, NewYork-Presbyterian Hospital / West Chester Division and NewYork – Presbyterian Hospital / The Allen Pavilion. Weill Cornell Medical College is the first of U.S. Medical school with a degree in medicine serves offering and features a strong global presence in Austria, Brazil, Tanzania, Turkey and Qatari.